Joint Filing Agreement
Exhibit 1
In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as
amended, each of the undersigned does hereby consent and agree to the joint filing on behalf of
each of them of a Statement on Schedule 13D and all amendments thereto with respect to the Common
Stock, par value $0.05 per share, of PharmaFrontiers Corp. beneficially owned by each of them, and
to the inclusion of this Joint Filing Agreement as an exhibit thereto.
Date:
|
April 24, 2006 | |||||
| XXXXXX & XXXXXXXX XXXXX FOUNDATION | CHASWIL, LTD. | |||||
By:
|
/s/ Xxxxx X. Xxxxxx | By: | /s/ Xxxxxxx X. Xxxxxxxx | |||
| Xxxxx X. Xxxxxx | Xxxxxxx X. Xxxxxxxx | |||||
| Executive Director | President | |||||
| ALKEK & XXXXXXXX VENTURES LTD. | DLD FAMILY INVESTMENTS, LLC | |||||
By:
|
/s/ Xxxxx X. Xxxxxx | By: | /s/ Xxxxx Xxxxx | |||
| Xxxxx X. Xxxxxx | Xxxxx Xxxxx | |||||
| Attorney-in-Fact | Vice President | |||||
| XXXXXX X. XXXXXX | XXXXX X. XXXXXX | |||||
By:
|
/s/ Xxxxxx X. Xxxxxx | By: | /s/ Xxxxx X. Xxxxxx | |||
| XXX X. XXXXXX | XXXXX XXXXXX XXXXXXXX | |||||
By:
|
/s/ Xxx X. Xxxxxx | By: | /s/ Xxxxx Xxxxxx Xxxxxxxx | |||
15
